605507.SS
605507.SS
CNE100004NS2
GUOBANG PHARMA LTD
Loading chart...

Company Profile

Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.

Related stocks

603456.SS
603456.SS • China
ZHEJIANG JIUZHOU PHARMACEUTICAL
16.31 CNY
2.14B USD 1Y -20.9%
600867.SS
600867.SS • China
TONGHUA DONGBAO MEDICINES CO LT
7.88 CNY
2.31B USD 1Y -7%
002755.SZ
002755.SZ • China
ASK PHARM
13.34 CNY
1.85B USD 1Y -32.7%
600267.SS
600267.SS • China
ZHEJIANG HISUN PHARMACEUTICAL C
11.94 CNY
2.11B USD 1Y +13.5%
600211.SS
600211.SS • China
TIBET RHODIOLA PHARMACEUTICAL H
36.78 CNY
1.77B USD 1Y -22.9%
002399.SZ
002399.SZ • China
HEPALINK
9.89 CNY
2.17B USD 1Y -16.7%
600420.SS
600420.SS • China
SHANGHAI SHYNDEC PHARMACEUTICAL
8.51 CNY
1.71B USD 1Y -20.2%
600572.SS
600572.SS • China
ZHEJIANG CONBA PHARMACEUTICAL C
4.41 CNY
1.68B USD 1Y +0.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
32.9% p.a.
Max Drawdown (5Y)
-61.9%
Sharpe Ratio (5Y)
-0.17
Beta Factor
0.15
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -61.9% in the extended horizon.
ende